Elshazly, A.M.; Xu, J.; Melhem, N.; Abdulnaby, A.; Elzahed, A.A.; Saleh, T.; Gewirtz, D.A.
Is Autophagy Targeting a Valid Adjuvant Strategy in Conjunction with Tyrosine Kinase Inhibitors? Cancers 2024, 16, 2989.
https://doi.org/10.3390/cancers16172989
AMA Style
Elshazly AM, Xu J, Melhem N, Abdulnaby A, Elzahed AA, Saleh T, Gewirtz DA.
Is Autophagy Targeting a Valid Adjuvant Strategy in Conjunction with Tyrosine Kinase Inhibitors? Cancers. 2024; 16(17):2989.
https://doi.org/10.3390/cancers16172989
Chicago/Turabian Style
Elshazly, Ahmed M., Jingwen Xu, Nebras Melhem, Alsayed Abdulnaby, Aya A. Elzahed, Tareq Saleh, and David A. Gewirtz.
2024. "Is Autophagy Targeting a Valid Adjuvant Strategy in Conjunction with Tyrosine Kinase Inhibitors?" Cancers 16, no. 17: 2989.
https://doi.org/10.3390/cancers16172989
APA Style
Elshazly, A. M., Xu, J., Melhem, N., Abdulnaby, A., Elzahed, A. A., Saleh, T., & Gewirtz, D. A.
(2024). Is Autophagy Targeting a Valid Adjuvant Strategy in Conjunction with Tyrosine Kinase Inhibitors? Cancers, 16(17), 2989.
https://doi.org/10.3390/cancers16172989
